Nasdaq: ACRV
Acrivon Therapeutics insiders
The officers, directors and 10% owners of Acrivon Therapeutics, Inc. who hold the most stock, valued at the live ACRV price.
$1.40
ACRV today −$160K (−10.26%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 4
- Their ACRV stock
- $21.6M
- Market value
- $60.1M
- Held by ranked insiders
- 35.9%
Insiders by value of ACRV holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Andreas Hadjimichael | 10% owner | 3,856,597 | $5.4M | 8.99% | 13722nd |
| 2 | Marcin Czernik | 10% owner | 3,850,704 | $5.4M | 8.97% | 13738th |
| 3 | Anastasis Nikolaou | 10% owner | 3,848,648 | $5.4M | 8.97% | 13743rd |
| 4 | Wiaczeslaw Smolokowski | 10% owner | 3,848,632 | $5.4M | 8.97% | 13744th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Acrivon Therapeutics; see each profile for the filing.